Australia's Arovella Therapeutics rises on completing process development

Arovella Therapeutics

05/06/2024 05:16

** Shares of Arovella Therapeutics  ALA.AX  rise as much as
13% to A$0.130, set for their best day since Apr. 26 - if gains
hold 
    ** Stock hits highest level since May 10 
    ** Biotechnology firm completes process development and
scale-up for manufacture of ALA-101, used for treating blood
cancers
    ** Says process suitable for large-scale and late-phase
clinical development 
    ** About 2.3 mln shares change hands, compared with the
30-day average volume of 1.2 mln

 (Reporting by Sneha Kumar in Bengaluru)
 ((Sneha.Kumar@thomsonreuters.com;))